The Shiv Texchem IPO is set to launch on October 8, 2024, aiming to raise approximately ₹101.35 crores. As a part of the SME IPO segment, Shiv Texchem has established a price band of ₹158 to ₹166 per equity share, with a minimum bid lot of 800 shares.
Founded on March 31, 2005, Shiv Texchem Limited operates as a private limited company in Mumbai under the Companies Act of 1956. The company specializes in importing and distributing hydrocarbon-based chemicals, playing a crucial role in sourcing these chemicals from international producers and suppliers for redistribution to domestic industries.
Shiv Texchem IPO Details
IPO Open Date: | October 8, 2024 |
IPO Close Date: | October 10, 2024 |
Face Value: | ₹10 per equity share |
IPO Price Band: | ₹158 to ₹166 per share |
Issue Size: | Approximately ₹101.35 Crores |
Fresh Issue: | Approximately ₹101.35 Crores |
Offer for Sale: | Not Applicable |
Issue Type: | Book Built Issue |
IPO Listing: | BSE SME |
Retail Quota: | Not more than 35% |
QIB Quota: | Not more than 50% |
NII Quota: | Not more than 15% |
Shiv Texchem IPO Important Dates
IPO Open Date: | October 8, 2024 |
IPO Close Date: | October 10, 2024 |
Basis of Allotment: | October 11, 2024 |
Refunds: | October 14, 2024 |
Credit to Demat Account: | October 14, 2024 |
IPO Listing Date: | October 15, 2024 |
Shiv Texchem IPO FAQs
What is Shiv Texchem IPO GMP Today?
Shiv Texchem IPO GMP is ₹- as of today.
What is the Shiv Texchem IPO Kostak Rate Today?
Shiv Texchem IPO Kostak Rate is ₹- as of today.
What is Shiv Texchem IPO Subject to Sauda Today?
Shiv Texchem IPO Subject to Sauda is ₹- as of today.
What is the expected return on Shiv Texchem IPO?
The expected return on Shiv Texchem IPO is -%.
Disclaimer:
- The IPO Grey Market Premium (GMP) mentioned is valid only for the specified date.
- We are not involved in the buying or selling of IPO forms on the Grey Market.
- Kostak Rate refers to the premium received by an individual who sells their IPO application before the allotment or listing.
- Investors are advised to evaluate IPOs based on the company’s fundamentals rather than the premium price, which may fluctuate before listing.